I think I found the residency résumé industry.
Mount Sinai lists Dr. Ratesh Khillan as a voluntary faculty physician/Assistant Clinical Professor affiliated with Beth Israel and Mount Sinai Brooklyn. Meanwhile, his private Brooklyn USCE business advertises Mount Sinai among its “teaching affiliates” while selling clinical rotations and residency-related services to IMGs.
His Brooklyn USCE business currently advertises:
$1,550: 4-week clinical rotation
+$399: opportunity to participate in research with Dr. Khillan
LORs on hospital letterhead for some rotations plus CV review, interview prep, residency signaling guidance and other Match services in larger packages.
Then I started looking at the research.
Two completely unrelated single-patient case reports, published two months apart, have the exact same 10 Brooklyn Cancer Care authors, just rearranged. One is a liver hematoma case and the other is Stage IV endometrial cancer.
And this isn’t even the only company selling residency research credentials.
USMLE Wise openly advertises $300 “co-author” placement on an active research project and $800 “lead-author” placement. They say participants perform substantive work and meet authorship standards, but those are literally the products being sold to residency applicants.
So foreign medical graduates can now shop for American clinical rotations, research opportunities, publication credits, hospital-letterhead recommendations, interview coaching and Match strategy.
Meanwhile we’re told a publication-heavy CV proves who the “best” residency candidate is.
How much of the American residency meritocracy is actually a credential marketplace?